Entourage Health Corp. (ETRGF)
| Previous Close | 0.0080 |
| Open | 0.0080 |
| Bid | N/A x N/A |
| Ask | N/A x N/A |
| Day's Range | 0.0080 - 0.0080 |
| 52 Week Range | 0.0021 - 0.0228 |
| Volume | |
| Avg. Volume | 20,611 |
| Market Cap | 2.467M |
| Beta (5Y Monthly) | 1.21 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- GlobeNewswire
Entourage Health Provides Corporate Update
Chief Legal Officer and Corporate Secretary to step down effective December 18, 2023 TORONTO, Dec. 05, 2023 (GLOBE NEWSWIRE) -- Entourage Health Corp. (TSX-V: ENTG) (OTCQX: ETRGF) (FSE:4WE) ("Entourage" or the "Company"), a Canadian producer and distributor of award-winning cannabis products, today announced that Vincent Doré, Entourage's Chief Legal Officer and Corporate Secretary, will step down to pursue other career opportunities, effective December 18, 2023. Mr. Doré joined Entourage Health
- GlobeNewswire
Entourage Health Reports Third Quarter 2023 Financial Results and Posts $12.2 Million in Total Revenue
Entourage sees the benefits of transitioning from cultivation and reports over $10 million to date in annualized cost savings.Gross Profit Before Fair Value Changes has surged to $2.4 million, indicating a substantial margin of 27% and a 149% year-over-year increase.Management is to host a conference call on November 28, 2023, at 10 a.m. Eastern Time. TORONTO, Nov. 28, 2023 (GLOBE NEWSWIRE) -- Entourage Health Corp. (TSX-V:ENTG) (OTCQX:ETRGF) (FSE:4WE) (“Entourage” or the “Company”), a Canadian
- GlobeNewswire
Entourage Health to Host Third Quarter 2023 Financial Results Call on November 28
TORONTO, Nov. 08, 2023 (GLOBE NEWSWIRE) -- Entourage Health Corp. (TSX-V:ENTG) (OTCQX:ETRGF) (FSE:4WE) (“Entourage” or the “Company”), a Canadian producer and distributor of award-winning cannabis products announced today it will file its third quarter 2023 financial statements and management’s discussion and analysis after-market on Monday, November 27, 2023. Entourage will host a conference call the following day on Tuesday, November 28, 2023, at 10 a.m. Eastern Time to review the results for
